The Los Angeles Center of the Multicenter AIDS Cohort Study (MACS) has followed 93 percent of the men who were seropositive at entry into the cohort or subsequently seroconverted since 1984 and 95 percent of the seronegative men who engage in high-risk activities with many partners. The MACS has published 678 papers on the epidemiologic, virologic, immunologic, genetic, behavioral, clinical, and neuropsychologic aspects of HIV/AIDS since 1984. This is a follow-up of the surviving men in the Los Angeles Center from 1999-2004. They include those who were seropositive at entry into the cohort, those who have seroconverted since entry into the cohort, seronegative men with many high-risk exposures, and a sample of seronegative men followed for quality control of technical procedures. The objectives of the proposal are: 1) to determine the long-term effectiveness of highly active retroviral therapy and newer therapies, 2) to determine the spectrum of individual responses to therapy, 3) to characterize the virologic parameters, immune responses and host genetic factors in progressors and non- progressors, 4) to characterize the nature of resistance to infection in HIV-1 seronegative men with many exposures to HIV-1, 5) to increase knowledge and understanding of prognostic markers, and 6) to further elucidate the epidemiology and pathogenesis of HIV-1 related malignancies. The men will continue to be followed semiannually for changes in behavior, health status, AIDS- defining and AIDS-related conditions, neuropsychologic performance, drug usage (including antiretroviral drugs), health services access and use, CD4+ and CD8+ levels, HIV-1 RNA levels, and CD38+CD8+ cell levels and expression. Seronegative men will be followed for seroconversion. Biopsies will continue to be sought and autopsies performed according to the MACS protocol. The UCLA Center will continue to collaborate with the MACS Executive Committee, the designated MACS HIV pathogenesis laboratories, and other investigations approved by the MACS Executive Committee. These continued studies should provide vital information on treatment effectiveness and on basic biologic mechanisms essential for development of more effective treatments and for development of effective therapeutic and preventive vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01AI035040-11S1
Application #
6940488
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Huebner, Robin E
Project Start
1993-04-01
Project End
2004-07-31
Budget Start
2004-04-01
Budget End
2004-07-31
Support Year
11
Fiscal Year
2004
Total Cost
$1,216,301
Indirect Cost
Name
University of California Los Angeles
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Robbins, Hilary A; Wiley, Dorothy J; Ho, Ken et al. (2018) Patterns of repeated anal cytology results among HIV-positive and HIV-negative men who have sex with men. Papillomavirus Res 5:143-149
Abraham, Alison G; Zhang, Long; Calkins, Keri et al. (2018) Vitamin D status and immune function reconstitution in HIV-infected men initiating therapy. AIDS 32:1069-1076
Price, Jennifer C; Seaberg, Eric C; Stosor, Valentina et al. (2018) Aspartate aminotransferase-to-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men. AIDS 32:2636-2638
Halec, Gordana; Waterboer, Tim; Brenner, Nicole et al. (2018) Serological Assessment of 18 Pathogens and Risk for AIDS-associated Non-Hodgkin Lymphoma. J Acquir Immune Defic Syndr :
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Wu, Minjie; Fatukasi, Omalara; Yang, Shaolin et al. (2018) HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition. AIDS 32:1803-1810
Armstrong, Nicole M; Surkan, Pamela J; Treisman, Glenn J et al. (2018) Optimal metrics for identifying long term patterns of depression in older HIV-infected and HIV-uninfected men who have sex with men. Aging Ment Health :1-8
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Tibuakuu, Martin; Zhao, Di; Saxena, Ankita et al. (2018) Low thigh muscle mass is associated with coronary artery stenosis among HIV-infected and HIV-uninfected men: The Multicenter AIDS Cohort Study (MACS). J Cardiovasc Comput Tomogr 12:131-138

Showing the most recent 10 out of 526 publications